Document Detail

Mechanisms of Action of Intravenous Immunoglobulin in Inflammatory Muscle Disease.
MedLine Citation:
PMID:  21503696     Owner:  NLM     Status:  Publisher    
Intravenous immunoglobulin (IVIG) is a unique immune-modulating therapy that has a wide range of effects on the immune system at multiple levels. This allows it to be used successfully in a variety of immune-mediated, systemic, and neurological disorders, including the inflammatory myopathies. It is likely that the specific action of IVIG varies depending on the underlying pathogenesis of a given disease. In dermatomyositis (DM), IVIG has been shown to diminish the activity of complement and deposition of membrane attack complex on capillaries and muscle fibers, the expression of adhesion molecules, and cytokine production. IVIG also appears to modify gene expression in the muscle of DM patients. The mechanism by which IVIG affects muscle in polymyositis and inclusion body myositis has not been well-studied. However, it may work via suppression of T-cell activation (including cytotoxic T cells) and migration into muscle tissue and alterations in cytokine production. IVIG generally yields the greatest therapeutic benefit in DM and is often of marginal utility in inclusion body myositis. It is generally considered as second-line or adjunctive therapy in the inflammatory myopathies.
Adam Quick; Rup Tandan
Related Documents :
18718356 - Conjugacy of horizontal saccades: application of binocular phase planes.
23915576 - Gluteus maximus and soleus compensate for simulated quadriceps atrophy and activation f...
9658346 - Magnetic resonance imaging of suprascapular nerve palsy.
21088606 - Why do older sprinters reach the finish line later?
22535786 - The mechanisms of the residual force enhancement after stretch of skeletal muscle: non-...
12224096 - Airflow through the auxiliary line of the laser fiber prevents ignition of intra-airway...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-19
Journal Detail:
Title:  Current rheumatology reports     Volume:  -     ISSN:  1534-6307     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888970     Medline TA:  Curr Rheumatol Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Ohio State University School of Medicine, Columbus, OH, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical assessment and management of cytopenias in lupus patients.
Next Document:  Different methods for monitoring intensity during water-based aerobic exercises.